Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

Friedreich's ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 ...

Friedreich's ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 and 15 years of age and ...

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the 'dark genome' that are responsible ...

Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...

"We are thrilled to welcome Kathy to Tessera," said Michael Severino, M.D., CEO. "Her extensive strategic and financial expertise, combined with deep sector knowledge, will be invaluable as we enter ...

Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced U.K. Medicines and Healthcare Products Regulatory Agency ...

Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced a planned leadership transition in its executive team. After ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

China has widened its lead over the US as the centre of global innovation, dominating 90 per cent of critical technologies.

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.

Scalable iPSC neuron manufacturing advances neuroscience, improving disease modeling, therapeutic development, and clinical readiness.